**UNITED      STATES**

**SECURITIES      AND EXCHANGE COMMISSION**

**WASHINGTON,      D.C. 20549**

----

**FORM      10-KSB/A**

**Amendment      No.1**

| x  | ANNUAL                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF                1934 |
|---------|--------------------------------------------------------------------------------------------------------------|

| o  | TRANSITION                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF                1934 |
|---------|------------------------------------------------------------------------------------------------------------------|

**R**
**XELITE,      INC.**

| **Delaware**(State                or Other Jurisdiction of Incorporation or Organization)                                                      | **62-0201385**(I.R.S.                Employer Identification No.) |
|------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|
|                                                                                                                                           |                                                              |
| **1404                North Main Street, Suite 200,****Meridian,                Idaho**(Address                of Principal Executive Offices) | **83642**(Zip                Code)                                |

**(202)      288-5550**

**None**

**Common      Stock, **
**par      value $0.001 per share**

----

**DOCUMENTS      INCORPORATED BY REFERENCE**

----

**TABLE      OF CONTENTS**

|                            |                      |                                                                                                                                                                     | Page   |
|---------------------------------|---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                            |                      |                                                                                                                                                                     |   |
| PART                  III  |                      |                                                                                                                                                                     |
|                            | Item                  9.  | Directors,                  Executive Officers, Promoters, Control Persons and Corporate Governance;                  Compliance With Section 16(a) of the Exchange Act. |   |
|                            | Item                  10. | Executive                  Compensation.                                                                                                                                 |   |
|                            | Item                  11. | Security                  Ownership of Certain Beneficial Owners and Management and Related                  Stockholder Matters.                                        |   |
|                            | Item                  12. | Certain                  Relationships and Related Transactions, and Director                  Independence.                                                             |   |
|                            | Item                  13. | Exhibits.                                                                                                                                                                |   |
|                            | Item                  14. | Principal                  Accountant Fees and Services.                                                                                                                 |   |

----

**EXPLANATORY      NOTE**

**FORWARD-LOOKING      STATEMENTS**

** **

----

**Part      III**

**Item      10. Directors, Executive Officers and Corporate Governance**

| **Name**                          |   | **Age** |   | **Position                with RxElite**                                  |
|-----------------------------------|--------|---------|--------|---------------------------------------------------------------------------|
|                              |   |    |   |                                                                      |
| Jonathan                Houssian  |   | 38      |   | President,                Chief Executive Officer, Treasurer and Director |
| Peter                W. Williams  |   | 71      |   | Chairman                of the Board                                      |
| Daniel                Chen        |   | 40      |   | Director                                                                  |
| Mark                Auerbach      |   | 69      |   | Director                                                                  |
| David                Rector       |   | 59      |   | Director                                                                  |
| Arie                Gutman, Ph.D. |   | 54      |   | Director,                President of Finetech Pharmaceutical             |
| Frank                Leo          |   | 52      |   | Director                                                                  |

*Jonathan      Houssian.*

*Peter      W. Williams.*

----

*Daniel      Chen.*
*Daniel      Chen.*

*Mark      Auerbach *

*David      Rector *

*Arie      Gutman*

*Frank      Leo *

----

**Management**

| **Name**                         |   | **Age** |   | **Position                with RxElite**                                                           |
|----------------------------------|--------|---------|--------|----------------------------------------------------------------------------------------------------|
|                             |   |    |   |                                                                                               |
| Jonathan                Houssian |   | 38      |   | President,                Chief Executive Officer, Treasurer and Director                          |
| Earl                Sullivan     |   | 36      |   | Chief                Operating Officer                                                             |
| Rick                Schindewolf  |   | 46      |   | Senior                Vice President of                New Business Development                    |
| Shannon                Stith     |   | 28      |   | Vice                President of Finance, Principal Financial Officer and                Secretary |

*Earl      Sullivan.*

*Rick      Schindewolf*
** **

*Shannon      M. Stith*.      Ms.      Stith has served as our Vice President of Finance and Principal Financial      Officer since January 11, 2008 and as our Secretary since February 7, 2008.      Ms.      Stith served as Vice President and Chief Financial Officer at PCS      Edventures!.com, Inc. (PCSV.OB) from August 2005 through January 2008. From      March 2005 until August 2005, Ms. Stith was a chief accountant for Washington      Group International in the financial reporting department-internal reporting.      From May 2001 until February 2004, Ms. Stith was a Paralegal and Controller      with      Dykas, Shaver & Nipper LLP. Ms. Stith graduated from Boise State University      with a Bachelor of Business Administration in Finance and a Masters of Business      Administration in 2002 and 2003, respectively.

----

**Compensation      of Directors**

**Director      Compensation**

| **Name**                         |   | **Fees****Earned or Paid in****Cash** |   | **Option Awards (1)** |   | **Total** |   |
|----------------------------------|--------|------------------------------------------------------|--------|---------------------------------|--------|-----------|--------|
|                             |   |                                                 |   |                            |   |      |   |
| Peter                W. Williams |   | $                                                    | 17,625 |                            | $      | 200,000   | (2)    | $ | 217,625 |   |
|                             |   |                                                 |        |                            |   |           |   |   |  |   |
| Mark                Auerbach     |   | $                                                    | 15,125 |                            | $      | 200,000   | (2)    | $ | 215,125 |   |
|                             |   |                                                 |        |                            |   |           |   |   |  |   |
| David                Rector      |   | $                                                    | 15,250 |                            | $      | 338,289   | (3)    | $ | 353,539 |   |

| (1)    | Based                upon the aggregate grant date fair value calculated in accordance                with                SFAS 123R and using a Black-Scholes-Merton valuation model.                                                                                                                                                                                                               |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                     |
| (2)    | On                July 13, 2007, we granted a ten-year option to purchase 400,000 shares                of                our Common Stock at an exercise price of $0.60 per share to each                of                Messrs. Williams and Auerbach. Such options vest in four equal annual                installments commencing on the first anniversary from the date of                grant. |
|   |                                                                                                                                                                                                                                                                                                                                                                                                     |
| (3)    | On                October 11, 2007, we granted a ten-year option to purchase 400,000                shares                of our Common Stock at an exercise price of $0.60 per share to Mr.                Rector.                Such option vests in four equal annual installments commencing on                the                first anniversary from the date of                grant.          |

| Annual                Fee                                               |   | $      | 25,000 |    |
|-------------------------------------------------------------------------|--------|--------|--------|---------|
|                                                                    |   |   |   |    |
| Board                Meeting Fee                                        |   | $      | 1,500  | *  |
|                                                                    |   |   |   |    |
| Committee                Meeting Fee                                    |   | $      | 1,000  | *  |
|                                                                    |   |   |   |    |
| Chairman                of the Board                                    |   | $      | 15,000 |    |
|                                                                    |   |   |   |    |
| Audit                Committee Chair                                    |   | $      | 10,000 |    |
|                                                                    |   |   |   |    |
| Compensation                Committee Chair                             |   | $      | 7,500  |    |
|                                                                    |   |   |   |    |
| Nominating                and Corporate Governance                Chair |   | $      | 5,000  |    |
|                                                                    |   |   |   |    |
| Committee                Fee                                            |   | $      | 1,500  |    |

----

**Board      of Directors and Committees**

*Audit      Committee.*

*Compensation      Committee.*

*Nominating      and Corporate Governance Committee*

*Executive      Committee*

----

*Strategic      Planning Committee.*

**Meetings      of the Board and Committees**

**Code      of Ethics**

**COMMUNICATION      WITH DIRECTORS**

**COMPENSATION      AND COMMITTEE INTERLOCKS**

**AND      INSIDER PARTICIPATION**

----

**Item      11. **
**Executive      Compensation.**
** **

**Summary      Compensation Table**

| **Name                and Principal Position**                                                                |   | **Year** |   |  **Salary** |   |  **Bonus** |   | **Option****Awards****(1)** |    | **All Other                Compensation** |   |  **Total** |   |
|---------------------------------------------------------------------------------------------------------------|--------|----------|--------|------------------|--------|-----------------|--------|-----------------------------|---------|------------------------------------------------|--------|-----------------|--------|
| Daniel                Chen (2)                                                                                |   |     | 2007   |             | $      | 251,367         |   | $                           | 125,000 |                                           | $      | 189,000         |   | $ | 24,013 | (3) | $ | 589,380 |   |
| *Chief                Executive Officer,**Treasurer                *and                Director**             |   |     | 2006   |             | $      | 176,400         |   | $                           | 35,000  |                                           |   | -               |   | $ | 3,180 | (4) | $ | 214,580 |   |
|                                                                                                          |   |     |   |             |   |            |   |                        |    |                                           |   |            |   |   |   |   |   |   |   |
| Jonathan                Houssian                                                                              |   |     | 2007   |             | $      | 243,866         |   | $                           | 62,500  |                                           | $      | 216,014         |   | $ | 3,180 | (4) | $ | 525,560 |   |
| *President,                Chief Executive Officer, Chief Financial Officer and                Director* |   |     | 2006   |             | $      | 176,400         |   | $                           | 35,000  |                                           |   | -               |   | $ | 3,180 | (4) | $ | 214,580 |   |
|                                                                                                          |   |     |   |             |   |            |   |                        |    |                                           |   |            |   |   |   |   |   |   |   |
| Earl                Sullivan                                                                                  |   |     | 2007   |             | $      | 188,867         |   | $                           | 42,750  |                                           | $      | 144,984         |   | $ | 1,326 | (4) | $ | 377,927 |   |
| *Chief                Operating Officer*                                                                      |   |     | 2006   |             | $      | 146,800         |   | $                           | 20,000  |                                           |   | -               |   | $ | 249,278 | (5) | $ | 416,078 |   |

| (1)    | Based                upon the aggregate grant date fair value calculated in accordance                with FAS                No. 123(R), Share Based Payment. Our policy and assumptions made                in                valuation of share based payments are contained in Note 17 to our                December                31, 2007 financial statements.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (2)    | Mr.                Chen ceased performing the duties of Chief Executive Officer and                Treasurer on September 21, 2007.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (3)    | Consists                of compensation payable to Mr. Chen in connection with his                resignation as Chief Executive Officer and Treasurer on September 31,                2007.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (4)    | Represents                life insurance premiums paid by us on behalf of Messrs. Chen, Houssian                and                Sullivan. The beneficiary of the policies is the                Company.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (5)    | Consists                of life insurance premiums of $253 per year and a gain of $249,025                as a                result of the reduction of the exercise price of a warrant held by                Mr.                Sullivan to purchase 528,007 shares of our Common Stock at a price                of                $0.474 per share to a price of $0.00237 per share. 132,004 shares                subject                to the warrant remained unexercised and unvested as of December 31,                2006.                We valued the adjustment to the warrant exercise price according                to                Statement of Financial Accounting Standards No. 123 (revised 2004),                Share                Based Payments (SFAS 123R) using the Black-Scholes method. SFAS 123R                requires all stock-based awards, including employee stock options,                to be                recognized in the income statement based on their fair values. The                dollar                amount represents the total compensation expense for stock option                awards                to be recognized in our financial statements over the requisite service                period in accordance with SFAS 123R. For information regarding our                valuation of option awards, refer to Note 17 to our Consolidated                Financial                Statements. |

----

**Outstanding      Equity Awards at Fiscal Year-End**

|                             |   | **Option                awards**                                                                    |    |
|----------------------------------|--------|-----------------------------------------------------------------------------------------------------|---------|
| **Name**                         |   | **Number of Securities****Underlying****Unexercised Options ****Unexercisable** |    | **Option****Exercise****Price** |   | **Option Expiration****Date** |   |
|                             |   |                                                                                                |    |   |   |   |   |
| Daniel                Chen       |   |                                                                                                | 436,000 |   | $ | 0.66 |   |   | 07/05/2012 |   |
|                             |   |                                                                                                | 552,432 |   | $ | 0.85 |   |   | 10/29/2009 |   |
|                             |   |                                                                                                | 450,375 |   | $ | 0.60 |   |   | 10/29/2009 |   |
|                             |   |                                                                                                | 32,895  |   | $ | 0.76 |   |   | 12/31/2009 |   |
| Jonathan                Houssian |   |                                                                                                | 505,624 |   | $ | 0.66 |   |   | 07/05/2012 |   |
|                             |   |                                                                                                | 32,895  |   | $ | 0.76 |   |   | 12/31/2009 |   |
| Earl                Sullivan     |   |                                                                                                | 132,004 |   | $ | 0.00237 |   |   | 11/04/2010 |   |
|                             |   |                                                                                                | 259,825 |   | $ | 0.60 |   |   | 07/05/2017 |   |
|                             |   |                                                                                                | 70,960  |   | $ | 0.85 |   |   | 10/29/2009 |   |
|                             |   |                                                                                                | 25,000  |   | $ | 0.76 |   |   | 12/31/2009 |   |

**2007      Option Exercises and Stock Vested Table**

**Pension      Benefits and Deferred Compensation Plans**

**Employment      Agreements and Change-in-Control Agreements**

----

----

**ITEM      12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED      STOCKHOLDER MATTERS**

|   | ·  | each                person or entity known by us to beneficially own more than 5% of                our                Common Stock; |
|--------|--------------|--------------------------------------------------------------------------------------------------------------------------------------|
|   | ·  | each                of our directors;                                                                                                |
|   | ·  | each                of the executive officers; and                                                                                   |
|   | ·  | all                of our directors and executive officers as a                group.                                                |

| Beneficial                  Owner                                         |   |                    Shares Beneficially                  Owned |       | Percent ofClass (1) |   |
|---------------------------------------------------------------------------|--------|--------------------------------------------------------------------|------------|-------------------------------|--------|
| Daniel                  Chen                                              |   |                                                               | 10,018,257 | (2)                           |   | 8.51 | % |
| Jonathan                  Houssian                                        |   |                                                               | 8,162,188  | (3)                           |   | 6.96 | % |
| Tiburon                  LLC                                              |   |                                                               | 7,656,564  | (3)                           |   | 6.52 | % |
| Mark                  Auerbach                                            |   |                                                               | 474,999    | (4)                           |   | * |   |
| Peter                  W. Williams                                        |   |                                                               | 62,501     | (5)                           |   | * |   |
| Earl                  Sullivan                                            |   |                                                               | 1,503,785  | (6)                           |   | 1.29 | % |
| David                  Rector                                             |   |                                                               | -          |                          |   | - |   |
| Arie                  Gutman                                              |   |                                                               | 18,832,383 | (7)                           |   | 16.16 | % |
| Frank                  Leo                                                |   |                                                               | -          |                          |   | - |   |
| CastlerRigg                  Master Investments, Ltd.                     |   |                                                               | 33,564,199 | (8)                           |   | 28.86 | % |
| Directors                  and Executive Officers as a group (10 persons) |   |                                                               | 39,054,113 |                          |   | 32.60 | % |

----

----

| (1) | Based                on 116,315,303 shares of our Common Stock outstanding on April 10,                2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Includes                (i) 1,002,807 shares issuable upon exercise of currently exercisable                warrants and (ii) 436,000 shares issuable upon exercise of currently                exercisable stock options.                                                                                                                                                                                                                                                                                                                                                                                                       |
| (3) | Includes                (i) 505,624 shares issuable upon exercise of currently exercisable                stock                options and (ii) 7,129,653 shares held by Tiburon LLC and (iii) 532,905                shares issuable upon exercise of currently exercisable warrants held                by                Tiburon LLC. Jonathan Houssian, the managing member of Tiburon LLC,                exercises sole voting and dispositive power with respect to the shares                held by Tiburon LLC. Mr. Houssian disclaims beneficial ownership                with                respect to such shares. |
| (4) | Represents                (i) 316,667 shares held by Susan Auerbach and (ii) 158,333 shares                issuable                upon exercise of currently exercisable warrants held by Susan Auerbach.                Susan Auerbach is the wife of Mark Auerbach and exercises sole voting                and                dispositive power with the respect to shares held by her. Mr. Auerbach                disclaims beneficial ownership with respect to such                shares.                                                                                                                               |
| (5) | Includes                20,833 shares issuable upon exercise of currently exercisable warrants.                All shares are held as tenants in common by Mr. Williams and members                of                his family in which Mr. Williams has a 20% beneficial                ownership.                                                                                                                                                                                                                                                                                                                             |
| (6) | Includes                462,789 shares issuable upon exercise of currently exercisable                warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (7) | Includes                200,000 shares issuable upon exercise of currently exercisable                warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (8) | Includes                18,646,777 shares issuable upon exercise of currently exercisable                warrants                and 9,323,389 shares upon the conversion of a convertible note.                                                                                                                                                                                                                                                                                                                                                                                                                                 |

**Ssection      16(a) Beneficial Ownership Reporting Compliance and Related Person      Transactions**

**Section      16(a) Beneficial Ownership Reporting Compliance**

**ITEM      13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS**

----

**ITEM      14. PRINCIPAL ACCOUNTANT FEES AND SERVICES**

**Audit      Fees **

**Audit      Related Fees**

----

**Tax      Fees**

**All      Other Fees**

**Audit      Committee**

**Change      in Accountants**

----

**ITEM      15. EXHIBITS AND SCHEDULES**

**Exhibits.**

|  Exhibit                Number |   |  Description                                                                                                                                                                                                                            |
|-------------------------------------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1(1)                              |   | Agreement                and Plan of Merger and Reorganization, dated as of July 13, 2007,                by and                among Southridge Technology Group, Inc., RxElite Holdings Inc., and                RxElite Acquisition Corp. |
|                                |   |                                                                                                                                                                                                                                         |
| 3.1(2)                              |   | Certificate                of Incorporation of Southridge Technology Group, Inc.                                                                                                                                                             |
|                                |   |                                                                                                                                                                                                                                         |
| 3.2(8)                              |   | Amended                and Restated Bylaws of Southridge Technology Group,                Inc.                                                                                                                                               |
|                                |   |                                                                                                                                                                                                                                         |
| 3.3(9)                              |   | First                Amendment to Amended and Restated Bylaws                                                                                                                                                                                |
|                                |   |                                                                                                                                                                                                                                         |
| 10.1(6)                             |   | Letter                Agreement, dated January 18, 2008, between RxElite, Inc. and Castlerigg                Master Investments Ltd.                                                                                                         |
|                                |   |                                                                                                                                                                                                                                         |
| 10.2(3)                             |   | Securities                Purchase Agreement, dated as of December 31, 2007, between RxElite,                Inc.                and Castlerigg Master Investments Ltd.                                                                      |
|                                |   |                                                                                                                                                                                                                                         |
| 10.3(3)                             |   | Registration                Rights Agreement, dated as of December 31, 2007, between RxElite,                Inc. and                Castlerigg Master Investments Ltd.                                                                      |
|                                |   |                                                                                                                                                                                                                                         |
| 10.4(3)                             |   | Senior                Secured Convertible Note, dated December 31, 2007.                                                                                                                                                                     |
|                                |   |                                                                                                                                                                                                                                         |
| 10.5(3)                             |   | Series                A Warrant, dated December 31, 2007.                                                                                                                                                                                    |
|                                |   |                                                                                                                                                                                                                                         |
| 10.6(3)                             |   | Series B                Warrant, dated December 31, 2007.                                                                                                                                                                               |
|                                |   |                                                                                                                                                                                                                                         |
| 10.7(3)                             |   | Security                Agreement, dated as of December 31, 2007, by and among RxElite, Inc.,                RxElite Holdings, Inc. and Castlerigg Master Investments                Ltd.                                                    |
|                                |   |                                                                                                                                                                                                                                         |
| 10.8(3)                             |   | Pledge                Agreement, dated as of December 31, 2007, by and between RxElite,                Inc. and                Castlerigg Master Investments Ltd.                                                                            |
|                                |   |                                                                                                                                                                                                                                         |
| 10.9(4)                             |   | Asset                Purchase Agreement, dated as of January 4, 2008, by and between RxElite                Israel Ltd. and FineTech Laboratories, Ltd.                                                                                      |
|                                |   |                                                                                                                                                                                                                                         |
| 10.10(4)                            |   | Assignment                & Non-Competition Agreement, dated as of January 4, 2008, by and                between RxElite, Inc. and Dr. Arie Gutman                                                                                      |
|                                |   |                                                                                                                                                                                                                                         |
| 10.11(4)                            |   | Registration                Rights Agreement, dated as of January 4, 2008, by and between RxElite,                Inc. and Dr. Arie Gutman                                                                                                   |
|                                |   |                                                                                                                                                                                                                                         |
| 10.12(4)                            |   | Employment                Agreement, dated as of January 4, 2008, by and between RxElite, Inc.                and                Dr. Arie Gutman                                                                                             |

----

| 10.13(5) |   | Departure                Agreement and General Release, dated as of January 16, 2008, by and                between RxElite, Inc. and Daniel Chen                                                                                                                                                                                                                             |
|----------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.14(5) |   | Employment                Agreement, dated as of January 11, 2008, by and between RxElite,                Inc. and                Shannon Stith                                                                                                                                                                                                                               |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.15(7) |   | Employment                Agreement, dated as of January 21, 2008, by and between RxElite Holdings                Inc. and Rick Schindewolf                                                                                                                                                                                                                                   |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.16(1) |   | Second                Amended and Restated Employment Agreement, made as of November 27,                2006,                between RxElite Holdings Inc. and Jonathan Houssian                                                                                                                                                                                              |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.17(1) |   | Second                Amended and Restated Employment Agreement, made as of November 27,                2006,                between RxElite Holdings Inc. and Earl Sullivan                                                                                                                                                                                                  |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.18(1) |   | Stock                Purchase Agreement, dated as of July 13, 2007, by and among Southridge                Technology Group, Inc., Joseph M. Garzi and Sunodia Partners                LP.                                                                                                                                                                                    |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.21(1) |   | Stock                Purchase Agreement, dated as of January 19, 2007, by and between                RxElite                Holdings Inc. and the investors listed on Exhibit A                thereto.                                                                                                                                                                       |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.22(1) |   | Form                of First Amendment to Stock Purchase Agreement.                                                                                                                                                                                                                                                                                                           |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.23(1) |   | Form                of Amended and Restated Registration Rights Agreement.                                                                                                                                                                                                                                                                                                    |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.24(1) |   | Form                of Warrant Agreement.                                                                                                                                                                                                                                                                                                                                     |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.25(1) |   | Form                of Warrant Agreement issued pursuant to the Stock Purchase Agreement,                dated as of January 19, 2007.                                                                                                                                                                                                                                        |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.26(1) |   | Form                of First Amendment to Warrant Agreement.                                                                                                                                                                                                                                                                                                                  |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.27(1) |   | Form                of Escrow Agreement.                                                                                                                                                                                                                                                                                                                                      |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.28(1) |   | Stock                Purchase Agreement dated as of July 13, 2007 between Southridge Technology                Group, Inc., RxElite Holdings Inc. and International Capital Advisory                Inc..                                                                                                                                                                     |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.29(1) |   | Stock                Purchase Agreement dated as of July 13, 2007 between Southridge Technology                Group, Inc., RxElite Holdings Inc. and Mr. Wu Kong                King.                                                                                                                                                                                        |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.30(1) |   | Form                of Securities Purchase Agreement.                                                                                                                                                                                                                                                                                                                         |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.31(1) |   | First                Amended and Restated Conversion Agreement, dated as of April 26,                2007, by                and among RxElite Holdings Inc. and each of the persons who were                holders                of Series A Preferred Stock of the RxElite Holdings Inc., par value                $0.01                per share as at October 17, 2006. |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.32(1) |   | Form                of RxElite Stockholder Warrant                                                                                                                                                                                                                                                                                                                            |
|     |   |                                                                                                                                                                                                                                                                                                                                                                          |
| 10.33(1) |   | Exclusive                Manufacturing and Distribution Agreement, dated as of June 9, 2004,                by and                between Minrad International, Inc. and RxElite Holdings                Inc.                                                                                                                                                                 |

----

| 10.34(1)                                                                               |   | RxElite                  Holdings Inc. 2007 Incentive Stock Plan.                                                                                                                                                                             |
|----------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 10.35(10)                                                                              |   | Form                  of Stock Option Award Agreement                                                                                                                                                                                         |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 10.36(2)                                                                               |   | Amended                  and Restated Advisory Consulting Agreement, dated as of July 13,                  2007, by                  and between International Capital Advisory Inc. and RxElite Holdings                  Inc.               |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 10.37(9)                                                                               |   | Consulting                  Agreement with MLF Group LLC                                                                                                                                                                                      |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 10.38(10)                                                                              |   | Lease                  Agreement, dated January 28, 2003, between RxHoldings, Inc. and                  M & M                  Management, and Addendum thereto, as of December 9, 2006 and May                  1,                  2007 |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 21.1(10)                                                                               |   | List                  of Subsidiaries.                                                                                                                                                                                                        |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 31.1*                                                                                  |   | Section                  302 Certification of Principal Executive Officer                                                                                                                                                                     |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 31.2*                                                                                  |   | Section                  302 Certification of Principal Financial Officer                                                                                                                                                                     |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 32.1*                                                                                  |   | Section                  906 Certification of Principal Executive Officer                                                                                                                                                                     |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| 32.2*                                                                                  |   | Section                  906 Certification of Principal Financial Officer                                                                                                                                                                     |
| _____________________________                  *Filed                  herewith   |
| (1)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  July 17, 2007.                                                                                          |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (2)                                                                                    |   | Previously                  filed as an Exhibit to Registration Statement on Form SB-2 filed                  with the                  SEC on December 22, 2005.                                                                             |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (3)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  January 3, 2008.                                                                                        |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (4)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  January 10, 2008.                                                                                       |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (5)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  January 16, 2008.                                                                                       |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (6)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  January 23, 2008.                                                                                       |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (7)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  January 24, 2008.                                                                                       |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (8)                                                                                    |   | Previously                  filed as an Exhibit on Current Report on Form 8-K/A filed with                  the SEC on                  August 3, 2007.                                                                                       |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (9)                                                                                    |   | Previously                  filed as an Exhibit to Current Report on Form 8-K filed with the                  SEC on                  March 13, 2008.                                                                                         |
|                                                                                   |   |                                                                                                                                                                                                                                          |
| (10)                                                                                   |   | Previously                  filed as an Exhibit to registration Statement on Form S-1 filed                  with the                  SEC on March 13, 2008                                                                                  |

----

**SIGNATURES**

| RxELITE,                INC. |
|------------------------------|
|                         |   |
| By:                          | /s/                Jonathan Houssian |
|                         | Jonathan                Houssian |
|                         | President                and Chief Executive Officer |

| April                  29, 2008                                                                                                                                                                                      | /s/                  Jonathan Houssian         |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|
| Jonathan                  HoussianPresident                  and Chief Executive Officer and Director(Principal                  Executive Officer)                                                                  |
|  April                  29, 2008                                                                                                                                                                                |  /s/                  Shannon Stith       |
| Shannon                  StithVice                  President of Finance, Principal Accounting Officer and                  Secretary(Principal                  Financial Officer and Principal Accounting Officer) |
|  April                  29, 2008                                                                                                                                                                                |  /s/                  Mark Auerbach  |
| Mark                  AuerbachDirector                                                                                                                                                                               |
|  April                  29, 2008                                                                                                                                                                                |  /s/                  David Rector        |
| David                  RectorDirector                                                                                                                                                                                |
|                                                                                                                                                                                                                 |                                           |
| April                  29, 2008                                                                                                                                                                                      |                                           |
| Daniel                  ChenDirector                                                                                                                                                                                 |
|                                                                                                                                                                                                                 |                                           |
| April                  29, 2008                                                                                                                                                                                      | /s/                  Peter W. Williams         |
| Peter                  W. WilliamsDirector                  and Chairman                                                                                                                                             |

----

|                          |                               |
|-------------------------------|------------------------------------|
| April                29, 2008 | Arie                GutmanDirector |
|                          |                               |
|                          | /s/                Frank Leo       |
| April                29, 2008 | Frank                LeoDirector   |

----